MIR4770

Across TCGA pan-cancer cohorts, MIR4770 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR4770 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR4770 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4770 expression acts as an unfavorable survival marker.

STAD and ESCA are the cancer types where MIR4770 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	II,III,IV	0.162	0.530	.001	54	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	45	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR4770–STAD (DFS)

Open the STAD breakdown →